Influence of dopamine, noradrenaline, and serotonin transporters on the pharmacogenetics of Atremorine in Parkinson's disease

Drug Dev Res. 2021 Aug;82(5):695-706. doi: 10.1002/ddr.21784. Epub 2021 Jan 17.

Abstract

Atremorine is a potent dopamine (DA) enhancer obtained by nondenaturing biotechnological processes from a genetic species of Vicia faba. Atremorine affects the neuronal dopaminergic system by acting as a neuroprotective agent against Parkinson's disease (PD). PD patients (N = 127) responded to a single dose of Atremorine (5 g, p.o.) 1 h after administration in a sex-, time-, dose-, and genotype-dependent fashion. Drug-free patients (N = 81) showed an increase in DA levels from 12.14 ± 0.34 pg/ml to 6463.21 ± 1306.90 pg/ml; and patients chronically treated with anti-PD drugs (N = 46) showed an increase in DA levels from 1321.53 ± 389.94 pg/ml to 16,028.54 ± 4783.98 pg/ml, indicating that Atremorine potentiates the dopaminergic effect of conventional anti-PD drugs. The variability in Atremorine-induced DA response is strongly attributable to pharmacogenetic factors. Polymorphic variants in pathogenic, mechanistic, metabolic, transporter, and pleiotropic genes influence the DA response to Atremorine. Genetic variation in the DA (SLC6A3; rs460000), noradrenaline (NA) (SLC6A2; rs12708954, rs3785143, rs5569), and serotonin (5-HT) transporter (SLC6A4; rs2020934, rs2020936, rs4251417, rs6354) genes exert a genotype-dependent Atremorine-induced DA response in PD, with potential impact on the DA-related pharmacogenetic outcome and minimum effects on NA and 5-HT levels.

Keywords: Atremorine; Parkinson's disease; neurotransmitter transporter genes.

MeSH terms

  • Aged
  • Biomarkers / analysis
  • Dopamine / metabolism*
  • Dopamine / pharmacology
  • Female
  • Humans
  • Levodopa / pharmacology*
  • Male
  • Middle Aged
  • Norepinephrine / metabolism*
  • Norepinephrine / pharmacology
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / genetics*
  • Pharmacogenetics
  • Serotonin / metabolism*
  • Serotonin / pharmacology

Substances

  • Atremorine
  • Biomarkers
  • Serotonin
  • Levodopa
  • Dopamine
  • Norepinephrine